Cargando…
Azithromycin Treatment vs Placebo in Children With Respiratory Syncytial Virus–Induced Respiratory Failure: A Phase 2 Randomized Clinical Trial
IMPORTANCE: Despite a high disease burden, there is no effective treatment for respiratory syncytial virus (RSV) infection. OBJECTIVES: To determine whether administration of azithromycin (AZM) to children with RSV-induced respiratory failure is safe and to define the effect of AZM therapy on nasal...
Autores principales: | Kong, Michele, Zhang, Wei Wei, Sewell, Kate, Gorman, Gregory, Kuo, Hui-Chien, Aban, Inmaculada, Ambalavanan, Namasivayam, Whitley, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180420/ https://www.ncbi.nlm.nih.gov/pubmed/32324238 http://dx.doi.org/10.1001/jamanetworkopen.2020.3482 |
Ejemplares similares
-
Comparison of Cardiac Events Associated With Azithromycin vs Amoxicillin
por: Patel, Haridarshan, et al.
Publicado: (2020) -
Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018
por: Hansen, Chelsea L., et al.
Publicado: (2022) -
Effect of Once-Weekly Azithromycin vs Placebo in Children With HIV-Associated Chronic Lung Disease: The BREATHE Randomized Clinical Trial
por: Ferrand, Rashida A., et al.
Publicado: (2020) -
Randomized trial of azithromycin to eradicate Ureaplasma respiratory colonization in preterm infants: 2-year outcomes
por: Viscardi, Rose M., et al.
Publicado: (2021) -
Evaluation of viral load in infants hospitalized with bronchiolitis caused by respiratory syncytial virus
por: Scagnolari, Carolina, et al.
Publicado: (2012)